Maxillofacial fractures
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged from 18 to 60 years(including 18 and 60 years), regardless of gender; 2. There is a clear history of trauma, clinical manifestations of maxillofacial bone fractures, clear fracture images can be seen on imaging examination, and a diagnosis of maxillofacial bone fractures; the treatment method is open reduction and internal fixation; 3. Volunteer to participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with maxillofacial fractures with severe soft tissue defects and wound infections; 2. Maxillofacial fractures with multiple injuries; 3. Those with local bone defect; 4. The investigator judges the benign and malignant tumor patients who cannot be selected and those who have received radiotherapy; 5. Those who have a history of osteoporosis and corresponding medication history through X-ray examination; 6. Severe liver, kidney, brain, cardiovascular, respiratory, endocrine and other system diseases who cannot withstand surgery; 7. Mental diseases, infectious diseases, drug abusers; 8. Systemic use of corticosteroid hormones (such as prednisone, dexamethasone, hydrocortisone, etc.); 9. Those who have participated in or are participating in other clinical trials within 3 months before the start of this trial; 10. People with a history of metal allergy; 11. Pregnant and lactating women, and women who plan to become pregnant within 3 years; 12. Those who have used degradable implantable devices; 13. Other circumstances judged by the researcher to be unsuitable for selection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Product efficiency; | — |
Secondary
| Measure | Time frame |
|---|---|
| Wound healing;Recovery of occlusal relationship;Openness; | — |
Countries
China
Contacts
The Third Affiliated Hospital of Air Force Military Medical University